-
Page 1 - Curriculum vitae of Giorgio Iervasi
[email protected]
E U R O P E A N
C U R R I C U L U M V I T A E
PERSONALINFORMATION
Name GIORGIOIERVASI
Address BORGOSANIACOPO,175LIVORNO
Telephone +390503152017
Fax +390503152651E-mail
[email protected];[email protected]
Nationality ITALIANDateofbirth LIVORNO,30/05/1954
WORKINGEXPERIENCE
•Dates 2019-present
•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy•Typeofbusinessorsector
ManagementofrelationshipsbetweenCNRandlocalandregionalandpublicandprivateInstitutions
•Occupationorpositionheld
PresidentofCNRResearchCampusofPisa•Mainactivitiesandresponsibilities
CoordinationsofactivitiesofCNRInstitutesofPisa
•Dates 2014-present
•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy•Typeofbusinessorsector
ScientificResearch•Occupationorpositionheld
Director,InstituteofClinicalPhysiology,NationalCouncilResearch(C.N.R.)
•Mainactivitiesandresponsibilities
ResponsibleforalltheresearchactivitiesoftheInstituteofClinicalPhysiology-CNR
•Dates 2015-present
•Nameandaddressofemployer
ScuolaSuperioreSant’AnnaPisa,Italy•Typeofbusinessorsector
TranslationalMedicine•Occupationorpositionheld
MemberofFacultyofTranslationalMedicinePhD
•Mainactivitiesandresponsibilities
TeachingactivitiesinCardiovascularEndocrineTranslationalMedicine
•Dates 2014•Nameandaddressofemployer
“SummerSchool”UniversityofPisa,Pisa,Italy
•Typeofbusinessorsector
CardiovascularPathophysiology•Occupationorpositionheld
Professor
•Mainactivitiesandresponsibilities
TeachingactivitiesinCardiovascularEndocrinologyPathophysiology
•Dates 2012-2014•Nameandaddressofemployer
CNR-TuscanyRegionG.MonasterioFoundation,Pisa,Italy
•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld
ScientificCoordinatorofCNR-TuscanyRegionG.MonasterioFoundation
•Mainactivitiesandresponsibilities
Coordinatorofallscientificactivities
-
Page 2 - Curriculum vitae of Giorgio Iervasi
[email protected]
•Dates 2012-2014•Nameandaddressofemployer
“ScientificAssociate”oftheEuropeanfoundedProjectFP7-ICT-2011-8"BioASQ”Achallengeonlarge-
scalebiomedicalsemanticindexingandquestionanswering•Typeofbusinessorsector
ScientificResearch
•Occupationorpositionheld
“ScientificAssociate”•Mainactivitiesandresponsibilities
ParticipationtothedevelopmentofanewBiomedicalWeb-basedplatform
•Dates 2012-present
•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy./TuscanyRegionGMonasterioFoundation-Pisa,Italy
•Typeofbusinessorsector
Thyroiddysfunctionandcardiovascularrisk•Occupationorpositionheld
MemberoftheSteeringCommitteeof“ThyroidStudiesCollaborationGroup”
•Mainactivitiesandresponsibilities The international scientific
association includes theworldwide recognized experts on
relationshipsbetweenthyroiddysfunctionandcardiovascularrisk
•Dates 2011-2013
•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy/TuscanyRegionGMonasterioFoundation-Pisa,Italy
•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolismClinical•Occupationorpositionheld
Head of Cardiovascular Endocrinology and Metabolism Clinical &
Experimental Department
C.N.R./TuscanyRegionGMonasterioFoundation•Mainactivitiesandresponsibilities
Responsible for the clinical and scientific activities of
Endocrinology and Metabolism Clinical &
ExperimentalDepartmentC.N.R./TuscanyRegionGMonasterioFoundation
•Dates 2011-present•Nameandaddressofemployer
MinistryofHealthandNationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy
•Typeofbusinessorsector
ScientificResearch•Occupationorpositionheld Member
•Mainactivitiesandresponsibilities Program Committee Member of
the ‘Procollo Intesa’ between the Ministry of Health and
CNR:integrationoftheHealthMinistryandCNRinitiatives
•Dates 2009-2014
•Nameandaddressofemployer
ScuolaSuperioreS.AnnaPisa,Italy•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolism
•Occupationorpositionheld
InvitedProfessorattheScuolaSuperioreS.Anna•Mainactivitiesandresponsibilities
TeachingactivitiesinCardiovascularEndocrinologyandMetabolism
•Dates 2007-2013
•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy.•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld
ResearchDirector,C.N.R.InstituteofClinicalPhysiology
•Mainactivitiesandresponsibilities
Coordinatorofresearchactivities
•Dates 2006•Nameandaddressofemployer “Higher Education
Commission International Center for Chemical and Biological
Sciences ” (HEJ),
ResearchInstituteofChemistry,Karachi,Pakistan•Typeofbusinessorsector
ChemicalandBiologicalSciences•Occupationorpositionheld
InvitedProfessor
•Mainactivitiesandresponsibilities
6“On–lineLectures”(LecturesthroughVideoConferencing).
•Dates 2004•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy
•Typeofbusinessorsector Endocrinology•Occupationorpositionheld
Invitedmemberto“TreatmentofHypothyroidism:ALookAhead”CytomelAdvisoryBoardMeeting-
WashingtonDC–USA(Othermembers:Dr.I.Kein,NewYork,Dr.J.R.Garber,Boston,Dr.D.Ascheim,New
York, Dr. T. Bigos, Scarborough, Dr. P.W. Clyde, Virginia Beach,
Dr. S. Danzi, Manhasset, Dr.
J.Klemperer,Bangor,Dr.R.Levine,Nashua,Dr.S.J.Mendel,Ardmore)
•Mainactivitiesandresponsibilities
Expertscientificconsultant
•Dates 2003•Nameandaddressofemployer
AmericanAssociationforEradicationofHeartAttack–VulnerablePlaque(AEHA)
•Occupationorpositionheld
InvitedmemberoftheScientificAdvisoryBoard•Mainactivitiesandresponsibilities
Editorialactivities
-
Page 3 - Curriculum vitae of Giorgio Iervasi
[email protected]
•Dates 2001-2006•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy
•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld
SeniorResearcherC.N.R.,InstituteofClinicalPhysiology
•Mainactivitiesandresponsibilities
Responsibleofresearchprojects
•Dates 1998-2010•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy
•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld
Chief of the Cardiovascular Endocrine Research and Clinical Unit of
the C.N.R. Institute of Clinical
Physiology/G.MonasterioFoundation•Mainactivitiesandresponsibilities
Clinicalandresearchactivities
•Dates 1998-2004
•Nameandaddressofemployer
ScuolaSuperioreS.AnnaPisa,Italy,incollaborationwithIFC-CNRandtheInternationalHeartSchool,BergamoItaly
•Typeofbusinessorsector
“InternationalMasterinCardiology,Cardio-surgeryandcorrelatedAnesthesia”•Occupationorpositionheld
Professor
•Mainactivitiesandresponsibilities
Professorwithintheframeofthevariouseditionsofthe“InternationalMasterinCardiology,Cardio-surgeryandcorrelatedAnesthesia”
•Dates 1997-2000
•Nameandaddressofemployer
MinistryofEducation,UniversitiesandResearch(Italy)•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolism
•Occupationorpositionheld
Responsible•Mainactivitiesandresponsibilities
ResponsibleofWorkPackage2,CCCN1"Biologicalandmolecularbasesofcongenitalneonatalheart
diseases,neuroendocrinefactorsandcardiomyocytes:analysis,
identificationandcharacterizationofpossiblecorrelationsbetweencongenitalheartdiseasesandsystemicandintracellularmetabolismofthyroidhormones"oftheNationalProject"NeonatalcriticalcongenitalHeartDisease."
•Dates 1991-1997
•Nameandaddressofemployer
UniversityofPisa,Italy•Typeofbusinessorsector
InternalMedicineandNuclearMedicine•Occupationorpositionheld Invited
Professor Post graduate Schools for Doctors (Internal Medicine and
Nuclear Medicine
Specialties)•Mainactivitiesandresponsibilities
TeachingactivitiesinInternalMedicineandNuclearMedicine
•Dates 1991-1994
•Nameandaddressofemployer
UniversityofPisa,Italy•Typeofbusinessorsector "Elements of
Radiobiology, Radiation Dosimetry and Applied Biology of
non-ionized andMetabolic
StudieswithRadioactiveTracersinNuclearMedicine"•Occupationorpositionheld
InvitedadjunctProfessor
•Mainactivitiesandresponsibilities Teaching activities in
Elements of Radiobiology, Radiation Dosimetry and Applied Biology
of
non-ionizedandMetabolicStudieswithRadioactiveTracersinNuclearMedicine
•Dates 1991-1992
•Nameandaddressofemployer
UniversityofPisa,Italy•Typeofbusinessorsector
“GastroenterologyandDigestiveEndoscopy”
•Occupationorpositionheld
InvitedadjunctProfessor•Mainactivitiesandresponsibilities
TeachingactivitiesinNuclearMedicineGastroenterology
•Dates 1990
•Nameandaddressofemployer
NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy•Typeofbusinessorsector
CardiovascularEndocrinologyandMetabolism
•Occupationorpositionheld
ResearcherC.N.R.,InstituteofClinicalPhysiology•Mainactivitiesandresponsibilities
Researchactivities
EDUCATIONANDTRAINING
•Dates•Nameandtypeoforganisationprovidingeducationandtraining•Principalsubjects/occupational
skillscovered
June-December2015MIPPolitecnicodiMilanoGraduateSchoolofBusinessAdvancedCourse“ManagementpathforthedirectorsofscientificstructuresoftheCNR”-Directorofthecourse:ProfMArbaboldi
-
Page 4 - Curriculum vitae of Giorgio Iervasi
[email protected]
•Dates 1986
•Nameandtypeoforganisationprovidingeducationandtraining
UniversityofPisa,Pisa,Italy
•Principalsubjects/occupationalskillscovered
NuclearMedicine
•Levelinnationalclassification Specialization
•Dates
1983•Nameandtypeoforganisationprovidingeducationandtraining
UniversityofPisa,Pisa,Italy
•Principalsubjects/occupationalskillscovered
InternalMedicine
•Levelinnationalclassification Specialization
•Dates
1978•Nameandtypeoforganisationprovidingeducationandtraining
UniversityofPisa,Pisa,Italy
•Principalsubjects/occupationalskillscovered
Medicine
•Titleofqualificationawarded
GraduatedegreeinMedicine•Levelinnationalclassification MD
MOTHERTONGUE
Italian
OTHERLANGUAGES English•Reading Intermediate•Writing
Intermediate•Speaking Intermediate
OTHERLANGUAGES French
•Reading Basic•Writing Basic•Speaking Basic
• OTHERRELEVANT
INFORMATIONABOUTTHESCIENTIFICAND
PROFESSIONALCAREER
-MemberoftheSelectFacultytosubmitnominationfor2016RossPrizeMolecularMedicine.-PresidentofCNRExpertPanel(BiomedicalArea)fortheevaluationofresearchprojectsoftheItalianMinistryofEconomicDevelopment(MISE)-CNRCoordinatorofthe“CasaItalia”projectforthe“Exposuretoriskofpeopleandthings”.ManagementPathforDirectorsofScintificResearchDepartmentsofCNRNationalResearchCouncil–DirectorofCourseProf.MichelaArnaboldi–PolitecnicodiMilanoGraduateSchoolofBusiness–July/December2015InternationalexperienceEducation1998
Post-doctoral Course at the Albert Einstein College of Medicine and
Montefiore Medical Center" New York, U.S.A. 1996 Holder of CNR
extraordinary assignment, Central Scientific Activity Department,
for a three-month study stay at the NIH (Bethesda, USA)
Member:ManagingEditor:InternationalJournalofEndocrinologyEditorialBoard:FrontiersPhysiologyEditorialBoard:FrontiersEndocrinologyEditorialBoard:WorldJournalofDiabetesEditorialBoard:JournalofGeriatricCardiologyEditorialBoard:ISRNCardiology2009
EditoroftheBook“ThyroidandHeartFailureFromPathophysiologytoClinics”,SpringerVerlagPublisher.Reviewerfor:CirculationNatureReviewsEndocrinologyandMetabolismJournalofMolecularandCellularEndocrinology
-
Page 5 - Curriculum vitae of Giorgio Iervasi
[email protected]
JournalofClinicalEndocrinologyandMetabolismEndocrinologyAmericanJournalofPhysiologyEuropeanJournalofEndocrinologyCriticalCareClinicalEndocrinologyExperimentalPhysiologyAmericanJournalofCardiologyJournalofEndocrinologyEuropeanJournalofClinicalInvestigationThyroidMolecularandCellularEndocrinologyEndocrineEuropeanJournalofRadiologyRegulatoryPeptidesCriticalCareMedicineHormoneMetabolicResearchIntensiveCareMedicineBiochemistryandCellBiologyICRSCardiologyMedicalScienceMonitoring
Maininternationalinvitedlectures(last10years):”XVI EUROPEAN
CONGRESS OF ENDOCRINOLOGY; EUROPEAN SOCIETY OF ENDOCRINOLOGY”
3-7May2014,WROCLAWPoland;”Thyroiddysfunctionincriticallyillpatients:totreatornottotreat?“XV
LATINAMERICANTHYROID CONGRESS”, 21-23March 2013, FLORIANOPOLIS,
Brazil;
“ThyroidHormonereplacementtherapyandheartfailure:whenandhow””XV
LATIN AMERICAN THYROID CONGRESS”, 21-23 March 2013, FLORIANOPOLIS,
Brazil;“ProangiogeneticactionofTSHthroughitsmembranereceptor””XV
LATINAMERICANTHYROID CONGRESS”, 21-23March 2013, FLORIANOPOLIS,
Brazil;
“ThyroidHormoneandtheCardiovascularSystem:fromBasicConceptstoClinicalApplications”“CHINA
HEART CONGRESS”, Beijing, China, 11-14 August 2011; ”Thyroid
Hormone Treatment
inCardiacDiseases:MoreLightthanShadow”“14THINTERNATIONALTHYROIDCONGRESS”,Paris,11-16September2010;“ThelowT3syndromeincardiacpatientsanditstreatmentwithT3”“INTERNATIONAL
CARDIOLOGY CONGRESS: TRACK 1-15 2009: HEART FAILURE”, China;
“Thyroidfunctionandheartfailure”
Honors2003Awardas“FeaturedArticleoftheMonth"bytheAEHAInternationalSociety(AssociationfortheEradicationofHeartAttack)fortheArticle:"Low-T3Syndrome:astrongprognosticpredictorofdeathinpatientswithheartdisease"(Circulation2003;107:708-713)Maininternationalresearchsupport(last7years)-PartneroftheEuropeanCommunity-fundedSeventhFrameworkProgrammeThemeProjectCIP-ICT-PSP-2012,
Title: “OpenScienceLink- Open Semantically-enabled, Social-aware
Access to
ScientificData”.Mainongoingnationalresearchsupport(last7years)-Responsible
of three-year Italian Grant: “Study of the molecular, biochemical
and
metabolicmechanismsinvolvedinthecardioprotectiveeffectofT3”.
-
Page 6 - Curriculum vitae of Giorgio Iervasi
[email protected]
PUBBLICATIONS1.
CarpiA.,IervasiG.,NicoliniA.,DelCorsoL.,LevantiC.,ZucchelliG.C.,BianchiR.Serumthyroidhormoneconcentrationsandrecovery
ofTSHsecretionafterexcisionofautonomouslyfunctioningthyroidnodulesMetabolism1982;31(5):417-4202.
Nicolini A., Immacolato M., Lazzerini G., Iervasi G., Carpi A.
Effetti della associazione metimazomo-dibromotirosina sui
livelli
circolantidegliormonitiroideiedelTSHinPazientiipertiroideiFarmaci1983;4:3-83.
CarpiA.,IervasiG.,NicoliniA.,BianchiR.ClinicaluseoffreeserumthyroidhormonesassaysRAYSSciences1984;9(1):131-1424.
Bianchi R., Molea N., Cazzuola F., Fusani L., Iervasi G., Bertelli
P., FerdeghiniM.,Mariani G. Separazione HPLC delle iodotironine
siericheperstudisulmetabolismoperifericodegliormonitiroideiinvivo.LigandQuaterly1986:5(4):57-685.
BianchiR.,PiloA.,IervasiG.,VitekF.,FerdeghiniM.,CazzuolaF.,MoleaN.MulticompartmentalvsnoncompartmentalanalysisofT4
andT3kineticsinnormalsandhypothyroidpatients.NuklearmedizinF.K.SchattauerVerlag,1987,332-3346.
Bianchi R., Iervasi G., Pilo A., Vitek F., Ferdeghini M., Cazzuola
F., Giraudi G.F. Role of serum carrier proteins in the
peripheral
metabolismandtissuedistributionofthyroidhormonesinfamilialdysalbuminemichyperthyroxinemiaandcongenitalelevationofthyroxine-bindingglobulinJClinInvest1987;80:522-534
7. Carpi A., Nicolini A., Iervasi G., Toscano S., Giannessi.,
Luti R. Evaluation of a new pharmacological preparation containing
L-
Thyroxineinsolution:comparisonwithL-ThyroxineandTriiodotironinetabletsClinicalTrialsJournal1988;25(3):172-1808.
PiloA., IervasiG.,VitekF.,FerdeghiniM.,CazzuolaF.,BianchiR
.Thyroidalandperipheralproductionof3,5,3’-triiodothyronine in
humansbymulticompartmentalanalysisAmJPhysiol1990;258:E715-E7269.
PiloA.,ZucchelliG.C.,MalvanoR.,ClericoA.,IervasiG.SignoriniC.Interassayvariabilityofimmunometricmethodsforthyrotropinin
anexternalqualityassessmentsurvey:evidencethat
functionalsensitivity isnotalwaysadequate
forclinicaldecisionsClinChem1992;38:1345-9
10. Bianchi R., Iervasi G., Matteucci F., Turchi S., Cazzuola
F., Bellina R.C., Boni G., Molea N., Ferdeghini M., Toni M.G.,
Mariani G.
Chromatographic identification in serum of endogenously
radioiodinated thyroid hormones after iodine-131 whole
bodyscintigraphyinthefollow-upofpatientswithdifferentiatedthyroidcarcinomaJNuclMed1993;34:2032-37
11. Iervasi G. Clerico A., Berti S., Pilo A., Vitek F., Biagini
A., BarattoM.T., Bianchi R., Donato L. ANP kinetics in normalmen:
in vivo
measurementbyatracermethodandcorrelationwithsodiumintake.AmJPhysiol1993;264:F480-912.
PiloA.,IervasiG.,VitekF.,TurchiS.,BianchiR.DisposalanddistributionofrT3inhumans:anewdouble-tracerkineticstudyAmJ
Physiol1993;264(2pt1):E239-4913.
ClericoA.,IasconeM.R.,ManfrediC.andIervasiG.Theroleofnuclearmedicineintheassessmentoftheendocrinefunctionofthe
heartJNuclBiolMed1994;38:37-4614.
IervasiG.,ClericoA.,PiloA.,BertiS.,VitekF.,BiaginiA.,BianchiR.,DonatoL.Kineticstudyofatrialnatriureticpeptideinpatients
with idiopathic dilated cardiomyopathy: evidence for resistance
to biologic effects of the hormone even in patients with
mildmyocardialinvolvementJCardiovascPharmacol1994;24:626-37
15.
BiaginiA.,IervasiG.,ClericoA.,BertiS.,PiloA.,VitekF.,BoniniR.,BianchiR.,DonatoL.Peripheralthyroidhormonemetabolismin
patientswithcomplexventriculararrhythmiasAmJCardiol1995;75:630-316.
ClericoA.,IervasiG.,BertiS.,PiloA.,VitekF.,SalvadoriS.,MarastoniM.,ManfrediC.,DelChiccaM.G.,IasconeM.R.,BiaginiA.Invivo
measurementofANPoverallturnoverandidentificationotitsmainmetabolicpathwaysundersteadystateconditionsinhumansJEndocrinolInvest1995;18:194-204
17.
ClericoA.,IervasiG.,IasconeM.R.,ManfrediC.,SabatinoL.,BertelliA.,BertelliA.A.E.Evaluationoftheendocrinefunctionoftheheart
inhumans:Proposalforanintegratedapproachfortheassessmentofproduction,secretion,distributionanddegradationofAtrialNatriureticFactorandRelatedPeptidesIntJClinPharmacol1995;15:65-86
18.
ClericoA.,IervasiG.,ManfrediC.,SalvadoriS.,MarastoniM.,TurchiS.,DelChiccaM.G.,GiannessiD.,DelRYS.,AndreassiM.G.,Biagini
A.,DonatoL.Preparationofmono-radio-iodinatedtracersforstudyingtheinvivometabolismofatrialnatriureticpeptideinhumans.EurJNuclMed1995;22:997-1004
19.
ClericoA.,IervasiG.AlterationsinmetabolicclearanceofANPinheartfailure:howdoesitrelatetotheresitancetoANP?JCardFail
1995;1(4):323-32820.
IervasiG.,ClericoA.,BertiS.,PiloA.,BiaginiA.,BianchiR.,DonatoL.AlteredtissuedegradationanddistributionofAtrialNatriuretic
Peptide in patients with idiopathic dilated cardiomyopathy and
its relationshipwith clinical severity of the disease and
sodiumhandlingCirculation1995;91:2018-27
21. Manfredi C., Clerico A., Iervasi G., Turchi S., Cazzuola F.,
Berti S., Sabatino L., Biagini A. Measurement of serum amiodarone
and
desethylamiodaronebyHPLC:itsusefulnessinthefollow-upofarrhythmicpatientstreatedwithamiodaroneIntJClinPharmacol1995;15:87-93
22. MurziB.,
IervasiG.,MasiniS.,MoschettiG.,VaniniV.,ZucchelliG.C.,BiaginiA.Thyroidhormoneshomeostasisinpediatricpatients
duringandaftercardiopulmonaryby-passAnnThoracSurg1995;59:481-485
-
Page 7 - Curriculum vitae of Giorgio Iervasi
[email protected]
23.
ClericoA.,IervasiG.,IasconeM.R.,ManfrediC.,SabatinoL.,BiaginiA.Resistancetobiologicaleffectsofatrialnatriureticpeptidein
heartfailure.InternalMed1995;3:57-6424. Del Ry S.,
AndreassiM.G., Lazzerini G., Iervasi G., Clerico A., Biagini A.,
Giannessi D. Determination of endothelin binding sites in
bovineatriumandventriclemembranes:amodelforbindingstudiesinhumancardiactissueIntJTissReac1995;XVII(3):117-12425.
IervasiG.,ClericoA.,BertiS.,PiloA.,ManfrediC.,SabatinoL.,IasconeM.R.,PalmieriC.,BiaginiA.,DonatoL.Alteredperipheralthyroid
hormonemetabolisminpatientswithcomplexventriculararrhythmiasandnormalserumconcentrationsofthyroidhormonesandTSHThyroidologyClinExp1995;7:43-8
26. Iervasi G., Clerico A., Pilo A., Berti S., Vitek F., Biagini
A., Bianchi R., Donato L. Normalization of peripheral thyroid
hormone
metabolism induced by successful chronic amiodarone treatment in
patients with ventricular arrhythmias Eur J Clin
Invest1996;26:382-90
27. Berti S., Palmieri C., Ravani M., Bonini R., Iascone M.R.,
Clerico A., Manfredi C., Iervasi G., Biagini A. Acute enoximone
effect on
systemicandrenalhemodynamicsinpatientswithheartfailureCardiovascDrugTher1996;10:81-8728.
Clerico A., Iervasi G., Del Chicca M.G., Maffei S., Berti S.,
Sabatino L., Turchi S., Cazzuola F., Manfredi C., Biagini A.
Analytical
performanceandclinicalusefulnessofacommerciallyavailable IRMAkit
formeasuringatrialnatriureticpeptide
inpatientswithheartfailureClinChem1996;42:1627-33
29.
IervasiG.,ClericoA.,BoniniR.,ManfrediC.,RavaniM.,ForiniF.,PalmieriC.,TurchiS.,CazzuolaF.,MusettiM.,BiaginiA.Acuteeffects
of intravenous amiodarone administration on thyroid function in
arrhythmic patients: preliminary results Thyroidol Clin
Exp1996;8:21-27
30. ClericoA., Iervasi G., Forini F. Importance of
circulatorymodels in turnover studies of hormones rapidly cleared
from the blood
stream:theexampleofatrialnatriureticpeptideInternalMed1996;4:53-5631.
Carpi A., Ferrari E., Sagripanti A., Nicolini A., Iervasi G., De
Gaudio C., Romani R., Di Coscio G. Aspiration needle biopsy
refines
preoperativediagnosisofthyroidnodulesdefinesaspirationasmicrofollicularnoduleBiomedPharmacother1996;50(8):325-832.
IervasiG.,ClericoA.,BoniniR.,ManfrediC.,BertiS.,RavaniM.,PalmieriC.,CarpiA.,BiaginiA.,ChopraI.J.Acuteeffectsofamiodarone
administrationonthyroidfunctioninpatientswithcardiacarrhythmiaJClinEndocrinolMetab1997;82:275-8033.
IervasiG.,ClericoA.,PiloA.,VitekF.,BertiS.,PalmieriC.,RavaniM.,SabatinoL.,ManfrediC.,DelChiccaM.G.,BiaginiA.,DonatoL.
EvidencethatatrialnatriureticpeptidetissueextractionisnotchangedbylargeincreasesofitsplasmalevelsinducedbypacinginhumansJClinEndocrinolMetab1997;82:884-888
34.
IervasiG.,ClericoA.,ManfrediC.,SabatinoL.,BiaginiA.,ChopraI.J.Acuteeffectsofintravenousamiodaroneonsulphatemetabolites
ofthyroidhormonesinarrhythmicpatientsClinEndocrinol1997;47(6):699-70535.
PiloA., Iervasi G., ClericoA., Vitek F., Berti S., Palmieri A.,
Biagini A., Donato L. Circulatorymodel inmetabolic studies of
rapidly
renewedhormones:applicationtoANPkineticsAmJPhysiol(sez.“ModelinginPhysiology”)1998;274(3):E560-E57236.
VitekF.,PiloA.,PichJ.,IervasiG.,ZitkoM.,ClericoA.Applicabilityofacirculatorymodelfordeterminingtheparametersofkineticsof
endogenouslyproducedcompoundsSbornLek1998;99(4):539-54737.
IervasiG.,ClericoA.,BoniniR.,NannipieriM.,ManfrediC.,
SabatinoL.,BiaginiA.,DonatoL.Effectofantiarrhythmic therapywith
intravenous loading dose of amiodarone: evidence for an altered
response in diabetic patients Int J Clin Pharmacol
Res1998;18(3):109-20
38.
IervasiG.,ClericoA.,PiloA.,SabatinoL.,ManfrediC.,ForiniF.,DelChiccaM.G.,PalmieriC.,RavaniM.,DonatoL.Atrialnatriuretic
peptideisnotdegradedbythelungsinhumansJClinEndocrinolMetab1998;83(8):2898-90639.
Maffei S., ClericoA., IervasiG.,NannipieriM.,DelRy S.,
GiannessiD.,DonatoL. Circulating levels of
cardiacnatriuretichormones
measuredinwomenduringmenstrualcycleJEndocrinolInvest1999;22(1):1-540.
ClericoA., IervasiG.,Del ChiccaM.G., EmdinM.,Maffei
S.,NannipieriM., SabatinoL., Forini F.,ManfrediC.,DonatoL.,
Circulating
levelsofcardiacnatriureticpeptides(ANPandBNP)measuredbyhighlysensitiveandspecificimmunoradiometricassaysinnormalsubjectsandinpatientswithdifferentdegreesofheartfailureJEndocrinolInvest1998;21(3):170-9
41. Iervasi G., Manfredi C., Scarlattini M., Emdin M.,
Caratterizzazione e follow-up della funzione tiroidea nel paziente
trattato con
amiodaroneCardiolExtraosp1998;4:366-36942.
ClericoA.,IervasiG.,DelRyS.,GiannessiD.,Immunoassaymethodsforthemeasurementofnatriureticcardiachormones-ANP,BNP,
andrelatedpeptides-inhumansJClinicalLigandAssay1999;22:194-20443.
ClericoA.,IervasiG.,MarianiG.,Pathophysiologyrelevanceofmeasuringtheplasmalevelsofcardiacnatriureticpeptidehormones
inhumansHormMetabRes1999;31(9):487-9844.
ClericoA.,IervasiG.,PiloA.Turnoverstudiesoncardiacnatriureticpeptides:methodological,pathophysiologicalandtherapeutical
considerationsCurrentDrugMetabolism2000;1:85-105
-
Page 8 - Curriculum vitae of Giorgio Iervasi
[email protected]
45.
EmdinM.,PrataliL.andIervasiG.AbolishedvagaltoneassociatedwiththyrotoxicosistriggersprinzmetalvariantparoxysmalatrialfibrillationAnnInternMed2000;132(8):679
46. SabatinoL.,
IervasiG.,FerrazziP.,FrancesconiD.,ChopraI.J.Astudyof
iodothyronine5’-monodeiodinaseactivities innormaland
pathologicaltissuesinmanandtheircomparisonwithactivitiesinrattissuesLifeSciences2000;68:191-20247.
Colzani R.M., Emdin M., Conforti F., Passino C., Scarlattini M. and
Iervasi G. Hypertyroidism is associated with lenghtening of
ventricularrepolarizationClinEndocrinol2001;55(1):27-3248.
Sabatino L., Chopra I.J., Tanavoli S., Iacconi P. and Iervasi G. A
radioimmunoassay for type I iodothironine 5’-monodeiodinase in
humantissuesThyroid2001;11(8):733-73949. Forini F., Paolicchi
A., Pizzorusso T., Ratto G.M., Saviozzi M., Vanini V and Iervasi G.
3,5,3’-thiiodothyronine deprivation affects
phenotypeandintracellular(Ca2+)IofhumancardiomyocytesincultureCardiovascRes2001;51(2):322-3050.
Fommei E., Iervasi G. The role of thyroid hormone in blood pression
homeostasis: evidence from short-term hypothyroidism in
humans.JClinEndocrinolMetab2002;87:1996-200051.
SabatinoL.,CerilloA.G.,RipoliA.,PiloA.,GlauberM.,IervasiG.IsthelowT3stateacrucialfactordeterminigtheoutcomeofcoronary
arterybypasspatients?Evidencefromaclinicalpilotstudy.JEndocrinology2002;175:577-8652.
Iervasi G., PingitoreA., Landi P., RacitiM., Ripoli A.,
ScarlattiniM., L’AbbateA., Donato L. Low-T3 syndrome: a strong
prognostic
predictorofdeathinpatientswithheartdisease.Circulation2003;107:708-71353.
IervasiG.,PingitoreA.,LandiP.,RacitiM.,RipoliA.,ScarlattiniM.,L’AbbateA.,DonatoL.Lowtriiodothyronineandcardiovascular
disease.Circulation2003;108(4):authorreplye29-3054.
NicoliniG.,BalzanS.,ColzaniR.,ScarlattiniM.,TaddeiM.C.,andIervasiG.ErythrocyteNa+/K+-ATPaseisincreasedinsubjectswith
subclinicalhypothyroidism.ClinicalEndocrinology2004;60:705-71055.
Iervasi A., Iervasi G., Bottoni A., Boni G., Annichiarico C., Di
Cecco P., and Zucchelli GC.Diagnostic performance of a new
highly
sensitivethyroglobulinimmunoassay.JournalofEndocrinology2004;182:287-29456.
ForiniF.,NicoliniG.,BalzanS.,RattoGM.,MurziB.,VaniniV.,
IervasiG.Amiodaroneinhibitsthe3,5,3’-triiodothyronine-dependent
increase of sodium potassium adenosine triphosphatase activity
and concentration in human atrial myocardial tissue.
Thyroid2004;14(7):491-497
57.
ScosciaE.,BaglioniS.,EslamiA.,IervasiG.,MontiS.,TodiscoT.Lowtriiodothyronine(T3)state:apredictorofoutcomeinrespiratory
failure?Resultsofaclinicalpilotstudy.EuropeanJournalofEndocrinology2004;151(5):557-6058.
Gasbarri A., Marchetti C., Iervasi G., Bottoni A., Nicolini A.,
Bartolazzi A., Carpi A. From the bench to the bedside.
Galectin-3
immunodetectionforimprovingthepreoperativediagnosisofthefollicularthyroidnodules.BiomedPharmacother2004;25:356-59
59.
ColantuoniA.,MarchiafavaPL.,LapiD.,ForiniFS.,IervasiG.Theeffectsoftetraiodothyronineandtriiodothyronineonhamstercheek
pouchmicrocirculation.AmJPhysiolHeartCircPhysiol2005;288:H1931-193660.
PingitoreA.,LandiP.,TaddeiMC.,RipoliA.,L’AbbateA.,
IervasiG.Triiodothyronine levels
forriskstratificationofpatientswith
chronicheartfailure.AmericanJournalofMedicine2005;118:2:132-3661.
RipoliA.,PingitoreA.,FavilliB.,BottoniA.,TurchiS.,OsmanN.,DeMarchiD.,LombardiM.,L’AbbateA.,IervasiG.Doessubclinical
hypothyroidismaffectcardiacpumpperformance?EvidencefromaMagneticResonanceImagingstudy.JACC2005;45:439-4562.
SabatinoL.,ColantuoniA.,IervasiG.IstheVascularSystemaMainTargetforThyroidHormones?FromMolecularandBiochemical
FindingstoClinicalPerspectives.CurrentVascularPharmacology2005;3:133-14563.
PingitoreA.,IervasiG.Thyroid(dys)functioninheartfailure:isitapotentialtargetformedicaltreatment?Vascularhealthandrisk
management2005;1(2):97-10064.
PingitoreA.,IervasiG.Funzionetiroideaescompensocardiaco:dallenuoveevidenzeclinicheallepossibiliimplicazioniterapeutiche.
RecentiProgressiinMedicina2005;96(11):535-54165.
CarpiA.,NaccaratoAG.,IervasiG.,NicoliniA.,BevilacquaG.,ViacavaP.,CollecchiP.,LavraL.,MarchettiC.,SciacchitanoS.,Bartolazzi
A.Largeneedleaspirationbiopsyandgalectin-3determinationinselectedthyroidnoduleswithindeterminatedFNA-cytology.BrJCancer2006;95(2):204-9
66.
IervasiA.,IervasiG.,CarpiA.,ZucchelliGC.Serumthyroglobulinmeasurement:clinicalbackgroundandmainmethodologicalaspects
withclinicalimpact.Biomedicine&Pharmacotheraphy2006;60:414-42467.
PingitoreA., Iervasi G., BarisonA., Prontera C., Pratali L.,
EmdinM., GiannessiD., NegliaD. Early activation of an altered
thyroid
hormoneprofile inasymptomaticormildlysymptomatic idiopathic
leftventricular dysfunction.
JournalofCardiacFailure2006;12(7):520-526
68. Franchi D., Iervasi G., Cini D., Benassi A., Cristofani R.
Modello computerizzato per la Valutazione Integrata del Rischio
Cardiovascolare(VIRC):fattorinotiedemergenti.RivistaItalianad’Igiene2006;66(1-2):7-25
-
Page 9 - Curriculum vitae of Giorgio Iervasi
[email protected]
69. IervasiG.Thyroidandheartfailure.Thyroidology2006;17:1-970.
CarpiA.,NicoliniA.,MarchettiC.,
IervasiG.,AntonelliA.,CarpiF.Percutaneous
largeneedleaspirationbiopsyofpalpable thyroid
nodules:technicalanddiagnosticperformance.Histopathology2007;51:249-25771.
IervasiG.,MolinaroS.,LandiP.,TaddeiM.C.,GalliE.,MarianiF.,L’AbbateA.,PingitoreA.Associationbetweenincreasedmortalityand
mildthyroiddysfunctionincardiacpatients.ArchInternMed2007;167(14):1526-153272.
IervasiA.,IervasiG.,FerdeghiniM.,SolimeoC.,BottoniA.,RossiL.,ColatoC.,ZucchelliG.C.ClinicalrelevanceofhighlysensitiveTg
assayinmonitoringpatientstreatedfordifferentiatedthyroidcancer.ClinicalEndocrinology2007;67(3):434-44173.
SabatinoL.,GliozheniE.,MolinaroS.,BonottiA.,AzzolinaS.,PopoffG.,CarpiA.,IervasiG.ThyroidhormonereceptorandIGF1/IGFR
systems:Possiblerelationsinthehumanheart.BiomedPharmacother2007;61(8):457-62.Epub2007May22.74.
Balzan S., Nicolini G., Forini F., Boni G., Del Carratore R.,
Nicolini A., Carpi A., Iervasi G.Presence of a functional TSH
receptor on
humanerythrocytes.BiomedPharmacother2007;61(8):463-7.Epub2007May25.75.
PingitoreA.,DiBellaG.,LombardiM.,IervasiG.,StrataE.,AquaroG.D.,PositanoV.,DeMarchiD.,RossiG.,L'AbbateA.,RovaiD.The
obesityparadoxandmyocardialinfarctsize.JCardiovascMed(Hagerstown).2007Sep;8(9):713-776.
Pingitore A., Iervasi G. Triiodothyronine (T3) effects on
cardiovascular system in patients with heart failure. Recent
Patents on
CardiovascularDrugDiscovery2008;3:(1):19-27.Review.77.
PingitoreA.,GalliE.,BarisonA.,IervasiA.,ScarlattiniM.,NucciD.,L'AbbateA.,MariottiR.,IervasiG.Acuteeffectsoftriiodothyronine
replacement therapy in patientswith chronic heart failure and
low-t3 syndrome: a randomized, placebo-controlled study. J
ClinEndocrinolMetab.2008;93(4):1351-8
78.
CarpiA.,DiCoscioG.,IervasiG.,AntonelliA.,MechanickJ.,SciacchitanoS.,NicoliniA.Thyroidfineneedleaspiration:Howtoimprove
clinicians'confidenceandperformancewiththetechnique.CancerLett.2008;264(2):163-17179.
IervasiG.Iltumoredifferenziatotiroideo:principididiagnosi,stadiazioneetrattamento.LigandAssay2008;13(3):191-19680.
Balzan S., Frascarelli S., Nicolini G., Lubrano V., Forini F.,
Iervasi G., Zucchi R., Montali U. Acute infusion of recombinant
human
thyrotropininLangendorff-rathearts:Roleofathyrotropinreceptor.IntJCardiol.2009Jul;27(5):259-6381.
Passino C., Pingitore A., Landi P., Iervasi G. Prognostic value of
combined measurement of brain natriuretic peptide and
triiodothyronineinheartfailure.JCardFail.2009Feb;15(1):35-40.Epub2008Oct4.82.
GimelliA.,RossiG.,LandiP.,MarzulloP.,IervasiG.,L'AbbateA.,RovaiD.Stress/RestMyocardialPerfusionAbnormalitiesbyGated
SPECT:StilltheBestPredictorofCardiacEventsinStableIschemicHeartDisease.JNuclMed.2009Mar16.83.
Balzan S, Del Carratore R, Nicolini G, Forini F, Lubrano V, Simili
M, Benedetti PA, Iervasi G TSH induces co-localization of TSH
receptorandNa/K-ATPaseinhumanerythrocytes.CellBiochemFunct.2009:22;27(5):259-263.[Epubaheadofprint]84.
NannipieriM.,CecchettiF.,AnselminoM.,NicoliniG.,LaMacchiaS.,CamastraS.,M.RossiM.,IervasiG.,FerranniniE.Expressionof
thyrotropin and thyroid hormone receptors in adipose tissue of
subjectswithmorbid obesity and/or type 2 diabetes: effects
ofweightloss.InternationalJournalofObesity2009:33(9):1001-6
85. Coceani M., Iervasi G., Pingitore A., Carpeggiani C.,
L’Abbate A. Thyroid hormone and coronary artery disease: from
clinical
correlationstoprognosticimplications.ClinCardiol2009:32(7):380-38586.
Cini A., Carpi A., Mechanick J., Cini L., Camici M., Galetta F.,
Giardino R., Russo M.A., Iervasi G. Thyroid hormones and the
cardiovascularsystem;pathophysiologyandinterventions.BiomedicineandPharmacotherapy2009;63:742-75387.
Zucchelli G.C., Iervasi A., Ferdeghini M., Iervasi G. Serum
thyroglobulin measurement in the follow-up of patients treated
for
differentiatedthyroidcancer.QJNuclMedMolImaging.2009Oct;53(5):482-9.88.
Galli E., Pingitore A., Iervasi G. Thyroid hormone in the
pathopysiology of heart failure: clinical evidence. Heart Fail
Rev.
2010;15(2):155-6989.
LubranoV.,PingitoreA.,CarpiA.,IervasiG.Relationshipbetweentriiodothyronineandproinflammatorycytokinesinchronicheart
failure.BiomedicineandPharmacotherapy2010Mar;64(3):165-990.
Carpi A., Rossi G., Coscio G.D., Iervasi G., Nicolini A., Carpi F.,
Mechanick JI., Bartolazzi A. Galectin-3 detection on
large-needle
aspirationbiopsyimprovespreoperativeselectionofthyroidnodules:Aprospectivecohortstudy.AnnMed2010;42(1):70-891.
CerilloA.G.,StortiS.,ClericoA., IervasiG.Thyroid
functionandcardiacsurgery:whatshouldwemeasure,andwhen?AnnThorac
Surg.2010Mar;89(3):1010-1.92. Pingitore A., Iervasi G.,
GerdesMA. Letter by Pingitore et al regarding article, "DITPA
(3,5-diiodothyropropionic acid), a thyroid
hormone analog to treat heart failure: phase II trial
VeteransAffairs cooperative study". Circulation.
2010Mar16;121(10):e240;authorreplye241
-
Page 10 - Curriculum vitae of Giorgio Iervasi
[email protected]
93. GerdesM.A., IervasiG. Thyroid replacement therapy andheart
failure. ContemporaryReviews inCardiovascularMedicine
series.Circulation2010;122(4):385-393
94.
RodondiN.,DenElzenWP.,BauerD.C.,CappolaA.R.,RazviS.,WalshJ.P.,AsvoldB.O.,IervasiG.,ImaizumiM.,ColletT.H.,BremnerA.,
Maisonneuve P., Sgarbi J.A., KhawK.T., VanderpumpM.P., Newman
A.B., Cornuz J., Franklyn J.A.,Westendorp R.G., Vittinghoff
E.,Gussekloo J., for the Thyroid Studies Collaboration. Subclinical
Hypothyroidism and the Risk of Coronary Heart Disease
andMortality.JAMA2010Sep22;304(12):1365-1374.
95.
IervasiG.,ClericoA.Harmonizationoffreethyroidhormonetests:amissionimpossible?ClinChemMed2011;4996.
FranchiD,CiniD, IervasiG.AnewWeb-basedmedical tool
forassessmentandpreventionof comprehensivecardiovascular risk.
TherClinRiskManag.2011;7:59-68.Epub2011Feb17.97.
PingitoreA,ChenY,GerdesAM,IervasiG.Acutemyocardialinfarctionandthyroidfunction:Newpathophysiologicalandtherapeutic
perspectives.AnnMed.2011May1398.
CoceaniM,MolinaroS,ScaleseM,LandiP,CarpeggianiC,L'AbbateA,IervasiG,PingitoreA.Thyroidhormone,amiodaronetherapy,
andprognosisinleftventricularsystolicdysfunction.JEndocrinolInvest.2011;34(6):e144-14899.
Giovannini S, Zucchelli GC, Iervasi G, Iervasi A, Chiesa MR,
Mercuri A, Renieri A, Prontera C, Conte R, Clerico A.
Multicentre
comparisonoffreethyroidhormonesimmunoassays:theImmunocheckstudy.ClinChemLabMed2011;49100.
Mourouzis I , ForiniF ,PantosC , IervasiG
.Thyroidhormoneandcardiacdisease : frombasic concepts to clinical
application J
ThyroidRes.2011;2011:958626.Epub2011Jun19.101.
BalzanS,CarpiA,EvangelistaM,NicoliniG,PollastriA,BottoniA,IervasiG.AcuteeffectofTSHonoxygenationstateandvolumeof
erythrocytesfromsubjectsthyroidectomizedfordifferentiatedthyroidcarcinoma.iomedPharmacother.2011;65(5):381-4.Epub2011Jun17.
102.
ForiniF.,LionettiV.,ArdehaliH.,PucciA.,CecchettiF.,GhanefarM.,NicoliniG.,IchikawaY.,NannipieriM.,RecchiaF.A,IervasiG.Early
long-term L-T3 replacement rescues mitochondria and prevents
ischemic cardiac remodeling in rats. J Cell Mol Med.
2011Mar;15(3):514-24
103.
DelCarratoreR,CarpiA,BeffyP,LubranoV,GiorgettiL,MasertiBE,CarluccioMA,SimiliM,IervasiG,BalzanS.Itraconazoleinhibits
HMEC-1angiogenesis.BiomedicineandPharmacotherapy2012;66(4):312-317104.
MolinaroS,IervasiG,LorenzoniV,CoceaniM,LandiP,SrebotV,MarianiF,L’AbbateA,PingitoreA.PersistenceofMortalityRiskin
PatientsWithAcuteCardiacDiseasesandMildThyroidDysfunction.AmJMedSci.2012;343(1):65-70105.
GalliE,MarchiniM,SabaA,BertiS,TonaccheraM,VittiP,ScanlanTS,IervasiG,ZucchiR.Detectionof3-IodothyronamineinHuman
Patients:APreliminaryStudy.JClinEndocrinolMetab.2012;97(1):E69-E74Oct26106.
BalzanS,DelCarratoreR,NicoliniG,BeffyP, LubranoV,ForiniF,
IervasiG.Proangiogenic effectofTSH inhumanmicrovascular
endothelialcellstroughtitsmembranereceptor.JClinEndocrinolMetab.2012;97(5):1763-1770107.
MarchettiI,IervasiG,MazzantiMC,LessiF,TomeiS,NaccaratoAG,AretiniP,AlbertiB,DiCoscioG,andBevilacquaG.Detectionof
the BRAFV600E mutation in fine needle aspiration cytology of
thyroid papillary microcarcinoma cells selected by
manualmacrodissection:aneasytooltoimprovethepreoperativediagnosis.Thyroid2012;22(3):292-298
108.
IervasiG,ForiniF,SabatinoL.Aglassofwine:howgoodisgood?Theresveratrollesson.CritCareMed2012;40(11):3098-99109.
IervasiG,BottoniA,FilideiE.IsrecombinanthumanTSHaseffectiveasthyroidhormonewithdrawalindetectionandtreatmentof
metastaticdifferentiatedthyroidcancer?ExpertReviewofEndocrinologyandMetabolism2012;7(12):633-35110.
ColletTH,GusseklooJ,BauerDC,denElzenWP,CappolaAR,BalmerP,IervasiG,ÅsvoldBO,SgarbiJA,VölzkeH,GencerB,MacielRM,
Molinaro S, Bremner A, Luben RN,Maisonneuve P, Cornuz J, Newman
AB, KhawKT,Westendorp RG, Franklyn JA, Vittinghoff E,Walsh JP,
Rodondi N; Thyroid Studies Collaboration. Subclinical
hyperthyroidism and the risk of coronary heart disease
andmortality.ArchInternMed.2012May28;172(10):799-809.
111. Fontana M., Passino C., Poletti R., Zyw L., Prontera C.,
Scarlattini M., Clerico A., Emdin M., Iervasi G. Low
Triiodothyronine and
exercisecapacityinheartfailure.InternationalJournalofCardiology2012112.
CantinottiM,LorenzoniV,StortiS,MoschettiR,MurziB,MarottaM,CrocettiM,MolinaroS,ClericoA,PortmanM,IervasiG.Thyroid
andbrainnatriueticpeptideresponseinchildrenundergoingcardiacsurgeryforcongenitalheartdisease:age-relatedvariationsandprognosticvalue.CirculationJournal2013;77(1):188-97
113. Marraccini P, Bianchi M, Bottoni A, Mazzarisi A, Coceani M,
Molinaro S, Lorenzoni V, Landi P, Iervasi G. Prevalence of
thyroid
disfunction and effect of contrastmedium on thyroidmetabolism in
cardiac patients undergoing on coronary angiography.
ActaRadiologica2013;54(1):42-47
114. Iervasi G., Nicolini G. Thyroid hormone and cardiovascular
system: from basic concepts to clinical application. Internal
and
EmergencyMedicine,2013;8:71-74115. Vassalle C., Iervasi G.
Cathepsin K – A classical bone biomarker in cardiovascular disease:
the heart is not alone anymore.
Atherosclerosis2013;228:36-37
-
Page 11 - Curriculum vitae of Giorgio Iervasi
[email protected]
116.
NicoliniG,PittoL,KusmicC,BalzanS,SabatinoL,IervasiG,ForiniF.Newinsightintomechanismofcardioprotectionmediatedbythyroidhormones.JournalofThyroidResearch2013;2013:264387
117. CarpiA, RossiG,NicoliniA, IervasiG, RussoM,Mechanick J.Does
largeneedle aspirationbiopsy addpain to the thyroidnodule
evaluation?PLoSOne.2013;8(3):e58016.118. CantinottiM,ClericoA,
IervasiG.Age-anddisease-relatedvariations
inB-typenatriureticpeptideresponseafterpediatriccardiac
surgery.JThoracCardiovascSurg.2013May;145(5):1415-16119.
Adamopoulos S, Gouziouta A,Mantzouratou P, Laoutaris ID, Dritsas A,
CokkinosDV,Mourouzis I, Sfyrakis P, Iervasi G, Pantos C.
Thyroidhormonesignalingisalteredinresponsetophysicaltraininginpatientswithend-stageheartfailureandmechanicalassistdevices:potentialphysiologicalconsequences?InteractCardiovascThoracSurg2013;17(4):664-68
120.
MenicucciD,SebastianiL,CompariniA,PingitoreA,GhelarducciB,L’AbbateA,IervasiG,GemignaniA.Minimalchangesofthyroid
axis activity influence brain functions in young females
affected by subclinical hypothyroidism. Archives Italiennes de
Biologie2013;151:1-10
121. Cantinotti M, Iervasi G, Clerico A. B-type natriuretic
peptide in children undergoing pediatric cardiac surgery: just a
marker of
diseaseseveritystronglyrelatedtoageormuchmore?TheJournalofThoracicandCardiovascularSurgery2014;147(1):541122.
WeltmanNY,PingitoreA, IervasiG.Relationof triiodothyronine
tosubclinicalmyocardial injury inpatientswithchestpain.AmJ
Cardiology2013;112(3):465-66123.
CantinottiM,AssantaN,MurziB,IervasiG,SpadoniI.Echocardiographicdefinitionofrestrictivepatentforamenovale(PFO).Heart
2014;100:264-265124. BalzanS,DelCarratoreS,Nardulli C,
SabatinoL, SabatinoL, IervasiG.The stimulative effect
ofT3andT4onhumanmyocardial
endothelialcellproliferation,migrationandangiogenesis.JClinExpCardiology2013;4:12125.
Saba A, Donzelli R, Colligiani D, Raffaelli A, Nannipieri M, Kusmic
C, Dos Remedios CG, Simonides WS, Iervasi G, Zucchi R.
QuantificationofThyroxineand3,5,3’–TriiodothyronineinHumanandAnimalHeartsbyaNovelLiquidChromatography-TandemMassSpectometryMethod.HormMetabRes2014;46:1-7
126.
CerilloAG,StortiS,KallushiE,HaxhiademiD,MiceliA,MurziM,BertiS,GlauberM,ClericoA,
IervasiG.The lowtriiodothyronine
syndrome: a strong predictor of low cardiac output and death in
patients undergoing coronary artery bypass grafting. Annals
ofThoracicSurgery2014
127. CantinottiM,ScaleseM,MurziB,AssantaN,Spadoni
I,FestaP,DeLuciaV,CrocettiM,MarottaM,MolinaroS,LopezL,
IervasiG.
Echocardiographic nomograms for ventricular, valvular and
arterial dimensions in caucasian children with a special focus
onneonates,infantsandtoddlers.JAmSocEchocardiography2014;27(2):179-181
128.
CantinottiM,AssantaN,CrocettiM,MarottaM,MurziB,IervasiG.Limitationsofcurrentnomogramsinpediatricechocardiography:
justthetipoftheiceberg-acallforstandardization.JAmSocEchocardiography2014;27(3):339129.
GuiducciL,IervasiG,QuininesGalvanA.Ontheparadoxinsulinresistance/insulinhypersensivityandobesity:twotalesofthesame
story.ExpRevCardiovasc.Ther.201412(6):637:642130.
ArviaC,SicilianoV,ChatzianagnostouK,LawsG,QuinonesGalvanA,MamminiC,BertiS,MolinaroS,IervasiG;Conventionalinsulin
vs insulin infusion therapy in acute coronary syndrome diabetic
patients; World J Diabetes. 2014 Aug 15;5(4):562-8.
doi:10.4239/wjd.v5.i4.562
131.
SabatinoL,IervasiG,PingitoreA;Thyroidhormoneandheartfailure:frommyocardialprotectiontosystemicregulation.;ExpertRev
CardiovascTher.2014Oct;12(10):1227-36.doi:10.1586/14779072.2014.957674.Epub2014Sep1132.
Forini F, Kusmic C, Nicolini G, Mariani L, Zucchi R, Matteucci M,
Iervasi G, Pitto L; Triiodothyronine prevents cardiac
ischemia/reperfusion mitochondrial impairment and cell loss by
regulating miR30a/p53 axis.
Endocrinology.2014Nov;155(11):4581-90.doi:10.1210/en.2014-1106.Epub2014Aug19.
133. SabatinoL,LubranoV,BalzanS,KusmicC,DelTurcoS,
IervasiG.ThyroidhormonedeiodinasesD1,D2,andD3areexpressed in
human endothelial dermal microvascular line: effects of thyroid
hormones. Mol Cell Biochem.2015 Jan;399(1-2):87-94.
doi:10.1007/s11010-014-2235-8.Epub2014Oct11.
134.
BuneviciusA,IervasiG,BuneviciusR.Neuroprotectiveactionsofthyroidhormonesandlow-T3syndromeasabiomarkerinacute
cerebrovasculardisorders.ExpertRevNeurother.2015Mar;15(3):315-26.doi:10.1586/14737175.2015.1013465.Epub2015Feb11.
135.
ForiniF,NicoliniG,IervasiG.Mitochondriaaskeytargetsofcardioprotectionincardiacischemicdisease:roleofthyroidhormone
triiodothyronine.IntJMolSci.2015Mar19;16(3):6312-36.doi:10.3390/ijms16036312.
-
Page 12 - Curriculum vitae of Giorgio Iervasi
[email protected]
135.
ChakerL,BaumgartnerC,denElzenWP,IkramMA,BlumMR,ColletTH,BakkerSJ,DehghanA,DrechslerC,LubenRN,HofmanA,PortegiesML,MediciM,IervasiG,StottDJ,FordI,BremnerA,WannerC,FerrucciL,NewmanAB,DullaartRP,SgarbiJA,CeresiniG,Maciel
RM,WestendorpRG, Jukema JW, ImaizumiM, Franklyn JA, BauerDC,Walsh
JP, Razvi S, KhawKT, Cappola AR, VölzkeH,FrancoOH,Gussekloo
J,RodondiN,PeetersRP;ThyroidStudiesCollaboration.SubclinicalHypothyroidismandtheRiskofStrokeEvents
and Fatal Stroke: An Individual Participant Data Analysis. J Clin
Endocrinol Metab. 2015 Jun;100(6):2181-91.
doi:10.1210/jc.2015-1438.Epub2015Apr9.
137. Cantinotti M, Giordano R, Scalese M, Molinaro S, Murzi B,
Assanta N, Crocetti M, Marotta M, Ghione S, Iervasi G. Strengths
and
limitations of current pediatric bloodpressurenomograms: a
global overviewwith a special emphasis on regional differences
inneonatesandinfants.HypertensRes.2015Sep;38(9):577-87.doi:10.1038/hr.2015.45.Epub2015Apr16.
138. Åsvold BO, Vatten LJ, Bjøro T, BauerDC, Bremner A, Cappola
AR, Ceresini G, den ElzenWP, Ferrucci L, FrancoOH, Franklyn JA,
GusseklooJ,IervasiG,ImaizumiM,KearneyPM,KhawKT,MacielRM,NewmanAB,PeetersRP,PsatyBM,RazviS,SgarbiJA,StottDJ,TrompetS,VanderpumpMP,VölzkeH,WalshJP,WestendorpRG,RodondiN;ThyroidStudiesCollaboration.Thyroidfunctionwithinthenormalrangeandriskofcoronaryheartdisease:anindividualparticipantdataanalysisof14cohorts.JAMAInternMed.2015Jun;175(6):1037-47.doi:10.1001/jamainternmed.2015.0930.
139.
CantinottiM,GiordanoR,ScaleseM,MolinaroS,DellaPinaF,StortiS,ArcieriL,MurziB,MarottaM,PakV,PoliV,IervasiG,KuttyS,Clerico
A. Prognostic role of BNP in children undergoing surgery for
congenital heart disease: analysis of prediction
modelsincorporatingstandardriskfactors.ClinChemLabMed.2015Oct1;53(11):1839-46.doi:10.1515/cclm-2014-1084.
140.
CantinottiM,KuttyS,GiordanoR,AssantaN,MurziB,CrocettiM,MarottaM,
IervasiG.Reviewandstatus reportofpediatric left
ventricularsystolicstrainandstrainratenomograms.HeartFailRev.2015Sep;20(5):601-12.doi:10.1007/s10741-015-9492-9.141.
WangW,GuanH,GerdesAM,IervasiG,YangY,TangYD.ThyroidStatus,CardiacFunction,andMortalityinPatientsWithIdiopathic
DilatedCardiomyopathy.JClinEndocrinolMetab.2015Aug;100(8):3210-8.doi:10.1210/jc.2014-4159.Epub2015Jun8.142.
PingitoreA, LimaGP,Mastorci F, QuinonesA, Iervasi G, Vassalle C.
Exercise and oxidative stress: potential effects of antioxidant
dietarystrategiesinsports.Nutrition.2015Jul-Aug;31(7-8):916-22.doi:10.1016/j.nut.2015.02.005.Epub2015Feb19.143.
FusaroM,GianniniS,GallieniM,NoaleM,TripepiG,RossiniM,MessaP,RigottiP,PatiT,BarbisoniF,PiccoliA,AghiA,AlessiM,
Bonfante L, Fabris F, Zambon S, Sella S, Iervasi G, PlebaniM.
Calcimimetic and vitaminD analog use in hemodialyzedpatients
isassociatedwithincreasedlevelsofvitaminKdependentproteins.Endocrine.2015Jul1.[Epubaheadofprint]
144. ChatzianagnostouK,
IervasiG,VassalleC.ChallengesofLADADiagnosisandTreatment:LessonsFrom2CaseReports.AmJTher.
2015Sep24.[Epubaheadofprint]145
PingitoreA,NicoliniG,KusmicC,IervasiG,GrigoliniP,ForiniF.CardioprotectionandthyroidhormonesHeartFailRev.2016Mar24.
[Epubaheadofprint]146 Sbrana F, Genovesi D, Catapano GA,
Panchetti L, Bottoni A, Iervasi G. Dabigatran malabsorption in
amiodarone-induced
thyrotoxicosis:aclinicalreport.InternEmergMed.2016Mar17.[Epubaheadofprint]147
NicoliniG,ForiniF,KusmicC,PittoL,MarianiL,IervasiG.Earlyandshort-termtriiodothyroninesupplementationpreventsadverse
post-ischemiccardiacremodeling:roleoftransforminggrowthfactor-β1andanti-fibroticmiRNAsignaling.MolMed.2015Nov23.doi:10.2119/molmed.2015.00140.[Epubaheadofprint]
148
CantinottiM,GiordanoR,ScaleseM,MurziB,AssantaN,SpadoniI,CrocettiM,MarottaM,MolinaroS,KuttyS,IervasiG.Nomograms
formitral inflowDopplerandtissueDopplervelocities
inCaucasianchildren.
JCardiol.2015Nov9.pii:S0914-5087(15)00321-4.doi:10.1016/j.jjcc.2015.10.004.[Epubaheadofprint]
149
ForiniF,UcciferriN,KusmicC,NicoliniG,CecchettiniA,RocchiccioliS,CittiL,IervasiG.EvidencefromaProteomicApproach.Low
T3 State Is Correlated with Cardiac Mitochondrial Impairments
after Ischemia Reperfusion Injury: Int J Mol Sci. 2015
Nov6;16(11):26687-705.doi:10.3390/ijms161125973.
150
FusaroM,PlebaniM,IervasiG,GallieniM.VitaminKDeficiencyinChronicKidneyDisease:EvidenceIsBuildingUp.AmJNephrol.
2016Nov15;45(1):1-3.[Epubaheadofprint]151
JabbarA,PingitoreA,PearceSH,ZamanA,IervasiG,RazviS.Thyroidhormonesandcardiovasculardisease.NatRevCardiol.2016
Nov4.doi:10.1038/nrcardio.2016.174.[Epubaheadofprint]152
ChakerL,BaumgartnerC,denElzenWP,ColletTH,IkramMA,BlumMR,DehghanA,DrechslerC,LubenRN,PortegiesML,IervasiG,
MediciM,StottDJ,DullaartRP,FordI,BremnerA,NewmanAB,WannerC,SgarbiJA,DörrM,LongstrethWTJr,PsatyBM,FerrucciL,MacielRM,WestendorpRG,
JukemaJW,CeresiniG, ImaizumiM,HofmanA,BakkerSJ,Franklyn
JA,KhawKT,BauerDC,Walsh JP,Razvi S, Gussekloo J, VölzkeH, FrancoOH,
CappolaAR, RodondiN, PeetersRP; Thyroid Studies Collaboration..
Thyroid FunctionWithin the Reference Range and the Risk of Stroke:
An Individual Participant Data Analysis. J Clin Endocrinol Metab.
2016Nov;101(11):4270-4282.
153
FusaroM,GallieniM,RizzoMA,StucchiA,DelanayeP,CavalierE,MoysésRM,JorgettiV,IervasiG,GianniniS,FabrisF,AghiA,SellaS,
Galli F, Viola V, Plebani M. Vitamin K plasma levels
determination in human health. Clin Chem Lab Med. 2016 Oct 12.
pii:/j/cclm.ahead-of-print/cclm-2016-0783/cclm-2016-0783.xml.doi:10.1515/cclm-2016-0783.[Epubaheadofprint]
154
SabatinoL,KusmicC,NicoliniG,AmatoR,CasiniG,IervasiG,BalzanS.T3enhancesAng2inrataortainmyocardialI/R:comparison
withleftventricle.JMolEndocrinol.2016Oct;57(3):139-49.doi:10.1530/JME-16-0118.
-
Page 13 - Curriculum vitae of Giorgio Iervasi
[email protected]
155
FusaroM,D'AlessandroC,NoaleM,TripepiG,PlebaniM,VeroneseN,IervasiG,GianniniS,RossiniM,TarroniG,LucatelloS,VianelloA,
Santinello I, Bonfante L, Fabris F, Sella S, PiccoliA,NasoA,
CiurlinoD,AghiA,GallieniM, CupistiA. LowvitaminK1 intake
inhaemodialysispatients.ClinNutr.2016Apr28.pii:S0261-5614(16)30070-X.doi:10.1016/j.clnu.2016.04.024.[Epubaheadofprint]
156
CantinottiM,GiordanoR,ScaleseM,MurziB,AssantaN,SpadoniI,MauraC,MarcoM,MolinaroS,KuttyS,IervasiG.Nomogramsfor
two-dimensional echocardiography derived valvular and arterial
dimensions in Caucasian children. J Cardiol. 2016 Apr 23.
pii:S0914-5087(16)30029-6.doi:10.1016/j.jjcc.2016.03.010.[Epubaheadofprint]
157
CantinottiM,AssantaN,CrocettiM,SpadoniI,IervasiG.ChallengesinInterpretingPediatricNormativeLeftVentricularStrainData
and the Quest for Comprehensive Deformation Nomograms. J Am Soc
Echocardiogr. 2016 Jun;29(6):567-8.
doi:10.1016/j.echo.2016.03.005.
158 Donzelli R, Colligiani D, Kusmic C, Sabatini M, Lorenzini L,
Accorroni A, Nannipieri M, Saba A, Iervasi G, Zucchi R. Effect
of
HypothyroidismandHyperthyroidismonTissueThyroidHormoneConcentrationsinRat.EurThyroidJ.2016Mar;5(1):27-34.doi:10.1159/000443523.
159
CantinottiM,GiordanoR,ClementeA,AssantaN,MurziM,MurziB,CrocettiM,MarottaM,ScaleseM,KuttyS,IervasiG.Strengthsand
LimitationsofCurrentAdultNomograms for
theAortaObtainedbyNoninvasiveCardiovascular
Imaging.Echocardiography.2016Jul;33(7):1046-68.doi:10.1111/echo.13232.Review.
160
WangW,GuanH,FangW,ZhangK,GerdesAM,IervasiG,TangYD.FreeTriiodothyronineLevelCorrelateswithMyocardialInjury
and Prognosis in Idiopathic Dilated Cardiomyopathy: Evidence
from Cardiac MRI and SPECT/PET Imaging. Sci Rep. 2016
Dec22;6:39811.doi:10.1038/srep39811.
161 Bunevicius A, Deltuva VP, Tamasauskas S, Smith T, Laws ER,
Bunevicius R, Iervasi G, Tamasauskas A.Preoperative low tri-
iodothyronineconcentrationisassociatedwithworsehealthstatusandshorterfiveyearsurvivalofprimarybraintumorpatients.Oncotarget.2017Jan31;8(5):8648-8656.doi:10.18632/oncotarget.14376.
162
CantinottiM,KuttyS,FranchiE,PaterniM,ScaleseM,IervasiG,KoestenbergerM.Pediatricechocardiographicnomograms:Whathas
beendoneandwhatstillneedstobedone.TrendsCardiovascMed.2017Jul;27(5):336-349.doi:10.1016/j.tcm.2017.01.006.Epub2017Jan19.Review.
163
ClericoA,RipoliA,FortunatoA,AlfanoA,CarrozzaC,CorrealeM,DittadiR,GessoniG,MigliardiM,RizzardiS,PronteraC,MasottiS,
ZucchelliG,GuiottoC,IacovazziPA,IervasiG.HarmonizationprotocolsforTSHimmunoassays:amulticenterstudyinItaly.ItalianSectionoftheEuropeanLigandAssaySociety(ELAS).ClinChemLabMed.2017Oct26;55(11):1722-1733.doi:10.1515/cclm-2016-0899.
164
FerranniniE,IervasiG,CobbJ,NdreuR,NannipieriM.Insulinresistanceandnormalthyroidhormonelevels:prospectivestudyand
metabolomic analysis. Am J Physiol Endocrinol Metab. 2017 May
1;312(5):E429-E436. doi: 10.1152/ajpendo.00464.2016.
Epub2017Feb28.
165
CantinottiM,GiordanoR,EmdinM,AssantaN,CrocettiM,MarottaM,IervasiG,LopezL,KuttyS.Echocardiographicassessmentof
pediatric semilunar valve disease. Echocardiography. 2017
Sep;34(9):1360-1370. doi: 10.1111/echo.13527. Epub 2017 Mar
31.Review.
166 Cantinotti M, Giordano R, Scalese M, Molinaro S, Storti S,
Murzi B, Pak V, Poli V, Iervasi G, Clerico A. Diagnostic accuracy
and
prognosticvaluedofplasmaticCystatin-Cinchildrenundergoingpediatriccardiacsurgery.ClinChimActa.2017Aug;471:113-118.doi:10.1016/j.cca.2017.05.031.Epub2017May26.
167 Cantinotti M, Giordano R, Assanta N, Murzi B, Melo M,
Franchi E, Crocetti M, Iervasi G, Kutty S. Strengths, Limitations,
and
GeographicalDiscrepanciesintheEligibilityCriteriaforSportParticipationinYoungPatientsWithCongenitalHeartDisease.ClinJSportMed.2017Jul21.doi:10.1097/JSM.0000000000000474.[Epubaheadofprint]
168 CantinottiM, GiordanoR, ScaleseM, Franchi E, CoranaG,
AssantaN,Maura C,MarcoM,Molinaro S, KoestenbergerM, Iervasi G.
Nomogramsforechocardiographicrightventricularsub-costalviewdimensionsinhealthyCaucasianchildren:Anewapproachtomeasuretherightventricle.JCardiol.2018Feb;71(2):181-186.doi:10.1016/j.jjcc.2017.07.015.Epub2017Oct12.
169
FusaroM,GallieniM,AghiA,IervasiG,RizzoMA,StucchiA,NoaleM,TripepiG,NickolasT,VeroneseN,FabrisF,GianniniS,CalòL,
PiccoliA,MereuMC,CosmaiL,FerraroA,MagonaraF,SpinelloM,SellaS,PlebaniM.CigarettesmokingisassociatedwithdecreasedBone
Gla-protein (BGP) levels in hemodialysis patients. Curr Vasc
Pharmacol. 2017 Sep 19.
doi:10.2174/1570161115666170919182421.[Epubaheadofprint]
170 Guarino D, Nannipieri M, Iervasi G, Taddei S, Bruno RM. The
Role of the Autonomic Nervous System in the Pathophysiology of
Obesity.FrontPhysiol.2017Sep14;8:665.doi:10.3389/fphys.2017.00665.eCollection2017.Review.171
Hartwig V, Guiducci L,MarinelliM, Pistoia L, Tegrimi TM, Iervasi G,
Quinones-GalvanA, L'Abbate A.Multimodal Imaging for the
Detection of Brown Adipose Tissue Activation inWomen: A Pilot
Study Using NIRS and Infrared Thermography. J Healthc
Eng.2017;2017:5986452.doi:10.1155/2017/5986452.Epub2017Sep14.
172 BuneviciusA,DeltuvaV,LawsER,
IervasiG,TamsauskasA,BuneviciusR.PreoperativeN-terminalpro-B-typenatriureticpeptide
concertationandprognosisofbraintumorpatients:a5-yearfollowupstudy.SciRep.2017Nov7;7(1):14775.doi:10.1038/s41598-017-15394-6.
-
Page 14 - Curriculum vitae of Giorgio Iervasi
[email protected]
173 Cantinotti M, Giordano R, Corsini I, Dani C, Scalese M,
Murzi B, Assanta N, Spadoni I, Molinaro S, Kutty S, Iervasi G,
Franchi
E.EchocardiographicnomogramsforupperabdominalaortaDopplersystolicwavevaluesandsysto-diastolicdiametersvariationsinchildren.JCardiol.2018Apr;71(4):394-400.doi:10.1016/j.jjcc.2017.09.016.Epub2017Nov10.
174
FusaroM,MereuMC,AghiA,IervasiG,GallieniM.VitaminKandbone.ClinCasesMinerBoneMetab.2017May-Aug;14(2):200-206.
doi:10.11138/ccmbm/2017.14.1.200.Epub2017Oct25.Review.175
ZhangK,WangW,ZhaoS,KatzSD,IervasiG,GerdesAM,TangYD.Long-termprognosticvalueofcombinedfreetriiodothyronineand
lategadoliniumenhancementinnonischemicdilatedcardiomyopathy.ClinCardiol.2018Jan;41(1):96-103.doi:10.1002/clc.22858.Epub2018Jan23.
176 Bunevicius A, Radziunas A, Tamasauskas S, Tamasauskas A,
Laws ER, Iervasi G, Bunevicius R, Deltuva V. Prognostic role of
high
sensitivity C-reactive protein and interleukin-6 in glioma
andmeningioma patients. J Neurooncol. 2018 Jun;138(2):351-358.
doi:10.1007/s11060-018-2803-y.Epub2018Feb19.
177
CantinottiM,ScaleseM,GiordanoR,FranchiE,AssantaN,MarottaM,ViacavaC,MolinaroS,IervasiG,SantoroG,KoestenbergerM.
NormativeData for Left andRightVentricular Systolic Strain
inHealthyCaucasian ItalianChildrenbyTwo-Dimensional
Speckle-TrackingEchocardiography.JAmSocEchocardiogr.2018Jun;31(6):712-720.e6.doi:10.1016/j.echo.2018.01.006.Epub2018Mar8.
178 Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I,
Peeters R, Zaman A, Iervasi G. Thyroid Hormones and
Cardiovascular
FunctionandDiseases.JAmCollCardiol.2018Apr24;71(16):1781-1796.doi:10.1016/j.jacc.2018.02.045.Review.179
MeuweseCL,vanDiepenM,CappolaAR,SarnakMJ,ShlipakMG,BauerDC,FriedLP,IacovielloM,VaesB,DegryseJ,KhawKT,Luben
RN,ÅsvoldBO,BjøroT,VattenLJ,deCraenAJM,TrompetS,IervasiG,MolinaroS,CeresiniG,FerrucciL,DullaartRPF,BakkerSJL,JukemaJW,KearneyPM,StottDJ,PeetersRP,FrancoOH,VölzkeH,WalshJP,BremnerA,SgarbiJA,MacielRMB,ImaizumiM,OhishiW,DekkerFW,RodondiN,GusseklooJ,denElzenWPJ.Lowthyroidfunctionisnotassociatedwithanaccelerateddeteriorationinrenalfunction.ThyroidStudiesCollaboration.NephrolDialTransplant.2018Apr18.doi:10.1093/ndt/gfy071.[Epubaheadofprint]
180 Sabatino L, Balzan S, Kusmic C, Iervasi G. Modification of
gene expression profiling related to renin-angiotensin system in
an
ischemia/reperfusionratmodelafterT3infusion.MolCellBiochem.2018May8.doi:10.1007/s11010-018-3364-2.[Epubaheadofprint]
181 Sabatino L, Costagli C, Lapi D, Del Seppia C, Federighi G,
Balzan S, Colantuoni A,Iervasi G, Scuri R. Renin-Angiotensin
System
Responds to ProlongedHypotensive Effect Induced byMandibular
Extension in SpontaneouslyHypertensive Rats. Front
Physiol.2018Nov15;9:1613.doi:10.3389/fphys.2018.01613.eCollection2018.
182
CantinottiM,ScaleseM,GiordanoR,FranchiE,AssantaN,MolinaroS,IervasiG,SantoroG,KoestenbergerM,KuttyS.LeftandRight
AtrialStraininHealthyCaucasianChildrenbyTwo-DimensionalSpeckle-TrackingEchocardiography.JAmSocEchocardiogr.2019Jan;32(1):165-168.e3.doi:10.1016/j.echo.2018.10.002.Epub2018Nov17.
183
CantinottiM,ScaleseM,GiordanoR,AssantaN,SantoroG,PaterniM,IervasiG,ChiappaE,KuttyS,KostenbergerM.Limitationsof
Current Fetal Echocardiography Nomograms for 2D Measures: A
Critical Overview and Analysis for Future Research. J Am
SocEchocardiogr.2018Dec;31(12):1368-1372.e10.doi:10.1016/j.echo.2018.09.018.Epub2018Oct16.
184 Forini F, Nicolini G, Kusmic C, D'Aurizio R, Rizzo M,
Baumgart M, Groth M, Doccini S, Iervasi G, Pitto L. Integrative
analysis of
differentially expressed genes andmiRNAs predicts complex
T3-mediated protective circuits in a rat model of cardiac
ischemiareperfusion.SciRep.2018Sep14;8(1):13870.doi:10.1038/s41598-018-32237-0.
185 GoriniF,
IervasiG,CoiA,PittoL,BianchiF.TheRoleofPolybrominatedDiphenylEthers
inThyroidCarcinogenesis: Is It aWeak
HypothesisoraHiddenReality?FromFactstoNewPerspectives.IntJEnvironResPublicHealth.2018Aug24;15(9).pii:E1834.doi:10.3390/ijerph15091834.Review.
186
WopereisDM,DuPuyRS,vanHeemstD,WalshJP,BremnerA,BakkerSJL,BauerDC,CappolaAR,CeresiniG,DegryseJ,DullaartRPF,
FellerM,FerrucciL,FlorianiC,FrancoOH,IacovielloM,IervasiG,ImaizumiM,JukemaJW,KhawKT,LubenRN,MolinaroS,NauckM,PatelKV,PeetersRP,PsatyBM,RazviS,SchindhelmRK,vanSchoorNM,StottDJ,VaesB,VanderpumpMPJ,VölzkeH,WestendorpRGJ,RodondiN,CobbaertCM,GusseklooJ,denElzenWPJ;ThyroidStudiesCollaboration.TheRelationBetweenThyroidFunctionand
Anemia: A Pooled Analysis of Individual Participant Data. J Clin
Endocrinol Metab. 2018 Oct 1;103(10):3658-3667.
doi:10.1210/jc.2018-00481.
187
WangWY,ZhangK,ZhaoW,GerdesAM,IervasiG,TangYD.Freetriiodothyroninelevelcorrelateswithstatinresponsivenessinacute
myocardialinfarction.JGeriatrCardiol.2018Apr;15(4):290-297.doi:10.11909/j.issn.1671-5411.2018.04.009.188
FusaroM,D'ArrigoG,PitinoA,IervasiG,TentoriF,RobinsonB,AghiA,BieberB,McculloghK,FabrisF,PlebaniM,GianniniS,Gallieni
M,TripepiG. Increasedriskofbone fractures inhemodialysispatients
treatedwithprotonpump inhibitors inrealworld: resultsfrom
theDialysis Outcomes and Practice Patterns Study (DOPPS).J
BoneMiner Res. 2019 Jul 31. doi: 10.1002/jbmr.3842.
[Epubaheadofprint]
189
ForiniF,NicoliniG,KusmicC,IervasiG.ProtectiveEffectsofEuthyroidismRestorationonMitochondriaFunctionandQualityControl
inCardiacPathophysiology.IntJMolSci.2019Jul10;20(14).pii:E3377.doi:10.3390/ijms20143377.Review.190
CantinottiM,KoestenbergerM,SantoroG,AssantaN,FranchiE,PaterniM,IervasiG,D'AndreaA,D'AscenziF,GiordanoR,Galderisi
M.Normalbasic2Dechocardiographicvaluestoscreenandfollowuptheathlete'sheartfromjuniorstoadults:Whatisknownandwhatismissing.Acriticalreview.EurJPrevCardiol.2019Jul2:2047487319862060.doi:10.1177/2047487319862060.[Epub
191 Lubrano V, Pingitore A, Traghella I, Storti S, Parri S,
Berti S, Ndreu R, Andrenelli A, Palmieri C,Iervasi G, Mastorci F,
Vassalle C.
Emerging Biomarkers of Oxidative Stress in Acute and Stable
Coronary Artery Disease: Levels and Determinants. Antioxidants
-
Page 15 - Curriculum vitae of Giorgio Iervasi
[email protected]
(Basel).2019May1;8(5).pii:E115.doi:10.3390/antiox8050115.192
CantinottiM,ScaleseM,GiordanoR,FranchiE,MarcheseP,AssantaN,MolinaroS,PaterniM,IervasiG,KoestenbergerM,KuttyS.
Three-DimensionalEchocardiographyDerivedNomogramsforLeftVentricularVolumesinHealthyCaucasianItalianChildren.JAmSocEchocardiogr.2019Jun;32(6):794-797.e1.doi:10.1016/j.echo.2019.01.020.Epub2019Apr2.Noabstractavailable.
193
CantinottiM,GiordanoR,ScaleseM,FranchiE,AssantaN,MolinaroS,MarcheseP,PaterniM,IervasiG,KuttyS,KoestenbergerM.
Nomograms of pulsed Doppler velocities, times, and velocity time
integrals for semilunar valves and great arteries in
healthyCaucasian children. Int J Cardiol. 2019 Jun 15;285:133-139.
doi: 10.1016/j.ijcard.2019.03.001. Epub 2019 Mar 3. No
abstractavailable.
194 Jalil B,HartwigV,MoroniD, Salvetti O, Benassi A, Jalil Z,
Pistoia L,Minutoli Tegrimi T, Quinones-GalvanA,Iervasi G,
L'AbbateA,
GuiducciL.APilotStudyofInfraredThermographyBasedAssessmentofLocalSkinTemperatureResponseinOverweightandLeanWomenduringOralGlucoseToleranceTest.JClinMed.2019Feb19;8(2).pii:E260.doi:10.3390/jcm8020260.
195
FusaroM,GallieniM,AghiA,RizzoMA,IervasiG,NickolasTL,FabrisF,MereuMC,GianniniS,SellaS,GiustiA,PitinoA,D'ArrigoG,
RossiniM,GattiD,RaveraM,DiLulloL,BellasiA,BrunoriG,PiccoliA,TripepiG,PlebaniM.Osteocalcin(boneGLAprotein)levels,vascular
calcifications, vertebral fractures and mortality in hemodialysis
patients with diabetes mellitus. J Nephrol.
2019Aug;32(4):635-643.doi:10.1007/s40620-019-00595-1.Epub2019Feb13.
196
PingitoreA,MastorciF,PiaggiP,AquaroGD,MolinaroS,RavaniM,DeCaterinaA,TrianniG,NdreuR,BertiS,VassalleC,IervasiG.
UsefulnessofTriiodothyronineReplacementTherapyinPatientsWithSTElevationMyocardialInfarctionandBorderline/ReducedTriiodothyronineLevels(fromtheTHIRSTStudy).AmJCardiol.2019Mar15;123(6):905-912.doi:10.1016/j.amjcard.2018.12.020.Epub2018Dec18.
197 Voges I, Giordano R, Koestenberg M, Marchese P, Scalese M,
Ait-Ali L, Santoro G,Iervasi G, Valverde I, Kutty S, Cantinotti
M.
Nomograms for Cardiovascular Magnetic Resonance Measurements in
the Pediatric Age Group: To Define the Normal and theExpected
Abnormal Values in Corrected/Palliated Congenital Heart Disease: A
Systematic Review. J Magn Reson Imaging.
2019May;49(5):1222-1235.doi:10.1002/jmri.26614.Epub2019Jan7.Review.
198 Bunevicius, A., Laws, E.R., Saudargiene, A., Tamasauskas,
A., Iervasi, G., Deltuva, V., Smith, T.R., Bunevicius, R. Common
genetic
variationsofdeiodinasegenesandprognosisofbraintumorpatients.Endocrine.Volume66,Issue3,1December2019,Pages563-572
199 Ravera,M.,Nickolas,T.,Plebani,M.,
Iervasi,G.,Aghi,A.,Khairallah,P.,Gallieni,M.,Mereu,M.C.,Giannini,S.,Sella,S.,Zaninotto,M.,
Paoletti,E.,Bussalino,E.,DiLullo,L.,Bellasi,A.,Cosmai,L.,Foramitti,M.,Malberti,F.,Brandi,M.L.,Ferrari,S.,Tripepi,G.,Fusaro,M.Overweight-obesity
is associated with decreased vitamin K2 levels in hemodialysis
patients. Clinical Chemistry and LaboratoryMedicine2020
200 Cappellani, D., Papini, P., Pingitore, A., Tomisti,
L.,Mantuano,M., Di Certo, A.M.,Manetti, L.,Marconcini, G.,
Scattina, I., Urbani, C.,
Morganti,R.,Marcocci,C.,Materazzi,G.,Iervasi,G.,Martino,E.,Bartalena,L.,Bogazzi,F.ComparisonBetweenTotalThyroidectomyandMedical
Therapy for Amiodarone-Induced Thyrotoxicosis. The Journal of
clinical endocrinology andmetabolismVolume
105,Issue1,1January2020
201
Gorini,F.,Bustaffa,E.,Coi,A.,Iervasi,G.,Bianchi,F.Bisphenolsasenvironmentaltriggersofthyroiddysfunction:Cluesandevidence.
InternationalJournalofEnvironmentalResearchandPublicHealth,2020,17(8),2654.202
Cantinotti, M., Scalese, M., Giordano, R., Franchi, E., Marchese,
P., Vicava, C., Assanta, N., Iervasi, G., Kutty, S., Koestenberger,
M.
Pediatricnomogramsforleftventriclebiplane2DvolumesinhealthyCaucasianchildren.Echocardiography.Volume37,Issue6,1June2020,Pages971-975
203
Cantinotti,M.,Koestenberger,M.,Santoro,G.,Assanta,N.,Franchi,E.,Paterni,M.,Iervasi,G.,D'Andrea,A.,D'Ascenzi,F.,Giordano,R.,
Galderisi,M.Normalbasic2Dechocardiographicvaluestoscreenandfollowuptheathlete'sheartfromjuniorstoadults:Whatisknownandwhatismissing.Acriticalreview.EuropeanJournalofPreventiveCardiology.Volume27,Issue12,1August2020,Pages1294-1306
204
Fusaro,M.,Cosmai,L.,Evenepoel,P.,Nickolas,T.L.,Cheung,A.M.,Aghi,A.,Tripepi,G.,Plebani,M.,Iervasi,G.,Vettor,R.,Zaninotto,M.,
Ravera,M.,Foramitti,M.,Giannini,S.,Sella,S.,Gallieni,M.VitaminKandkidneytransplantation.Nutrients.OpenAccessVolume12,Issue9,September2020,Articlenumber2717,Pages1-13.
205
Forini,F.,Nicolini,G.,Kusmic,C.,D'Aurizio,R.,Mercatanti,A.,Iervasi,G.,Pitto,L.T3CriticallyAffectstheMhrt/Brg1AxistoRegulate
theCardiacMHCSwitch:RoleofanEpigeneticCross-Talk.Cells.Volume9,Issue10,24September2020206
Forini,F.,Canale,P.,Nicolini,G.,Iervasi,G.Mitochondria-targeteddrugdeliveryincardiovasculardisease:Alongroadtonano-cardio
medicine.Pharmaceutics,2020,12(11),pp.1-24,1122207
Sabatino,L.,Kusmic,C.,
Iervasi,G.Modificationofcardiacthyroidhormonedeiodinasesexpressioninan
ischemia/reperfusionrat
modelafterT3infusion.MolecularandCellularBiochemistry,2020,475(1-2),pp.205-214.
CHAPTERSINBOOK1.
CarpiA,IervasiG,NicoliniA,BianchiR,UrbanoU,DiCoscioG.COneyearexperiencewithaspirationofthyroidnodules.In“Advances
inthyroidneoplasia”,AndreoliM.,RobbinsJ.,MonacoE.,Eds,FieldEducationalItalia,Roma,1981,pp.293-300
-
Page 16 - Curriculum vitae of Giorgio Iervasi
[email protected]
2. BianchiR, IervasiG “ LaTiroide” in “Semeiologia eDiagnostica
funzionale”, PaseroG,GiordaniR,Eds, CasaEditriceAmbrosiana,
Milano1985,pp.562-5733. Bianchi R, Iervasi G, Molea N, Cazzuola
F, Ferdeghini M, Pilo A Kinetic studies of thyroid hormones in
familial disalbuminemic
hyperthyroxinemia(FDH)andincongenitalTBGelevation(HTBG).PlenumPress,NewYork,1986,pp.499-5034.
Iervasi G, Boni G, FerdeghiniM “I Dosaggi Radioimmunologici” in
“Immunologia inMedicina” Dammacco F Ed, Casa Editrice Edi
Ermes,Milano1989,pp.1618-16305.
IervasiG,BertiS,VitekF,BiaginiA,ClericoA,PiloA,TurchiS,BarattoMT,CazzuolaF,BianchiRKineticsof
theatrialnatriuretic
peptideinhumansbyanewtracermethod.In“Radioactiveisotopesinclinicalmedicineandresearch”.F.K.Schattauered.SpringerVerlag,Stuttgart,NewYork1992,pp.322-5
6. Berti S, Palmieri C, BoniniR, RavaniM, ClericoA, Iervasi G,
Gazzetti P, Pugliese S, BiaginiAAcuteEnoximone effect on
systemic
hemodynamicrenal functionandhormonalactivation
inpatientswithheart failure.
In“MechanismandTherapyofHeartFailure”eds.P.K.Singal,R.E.BeamishandN.S.Dhalla,Boston,KluwerAcademicPublishers,1994
7. IervasiG, ClericoA, Berti S, PiloA, Vitek F,Manfredi C,
IasconeMR,Maffei S, BiaginiAPeripheral resistance to atrial
natriuretic
peptide in patients with idiopathic dilated cardiomyopathy. In
“Mechanism and Therapy of Heart Failure” eds. P.K. Singal,
R.E.BeamishandN.S.Dhalla,Boston,KluwerAcademicPublishers,1994
8.
VitekF,PiloA,IervasiG,ClericoA,BertiS,IasconeMR,ManfrediC,BiaginiA,BianchiR,DonatoLCirculatorymodelforinvivokinetic
studiesofatrialnatriureticpeptide(ANP) inhumans.Computers
inCardiology,BethesdaSeptember25-28,1994,
IEEEComputerSocietyPress,LosAlamos1994,pp.385-8
9.
IervasiG,EmdinMControlloneuroendocrinodelsistemacardiovascolare.
In“TrattatodiCardiologiaANMCO”,ExcerptaMedica–
ESIStampaMedica,Milano2000pp.133-148.10.
EmdinM.,IervasiG.Scompensocardiacoesistemaneuroendocrino.IQuadernidelCNR,2001,PrimulaMultimediaS.r.L11.
IervasiG,ZucchelliGC.Diagnosticabiochimicadellemalattietiroidee.In“Trattatoitalianodimedicinadilaboratorio.CasaEditrice
Piccin,Vol.VII,Capitolo15,2008pp.421–44812. Iervasi G, Pingitore
A. Heart failure, Iodine intake and thyroid hormones. In “
Comprehensive handbook on iodine: nutritional,
endocrineandpathologicalaspects.V.Preedy,G.N.Burrow,R.R.WatsonEds.,ElsevierInc.,OxfordAcademicPress2009:pp1073-1086
13.
IervasiG,FommeiE.HypertensionandHypothyroidism,athyroiddysfunctionfrequentlyassociatedwithaabnormaldietaryiodine
intake.In“Comprehensivehandbookoniodine:nutritional,endocrineandpathologicalaspects.V.Preedy,G.N.Burrow,R.R.WatsonEds.,ElsevierInc.,OxfordAcademicPress2009:pp1057-1071
14.
IervasiG.,SabatinoL.,NicoliniG.Lowtriiodothyroninesyndromeasapowerfulpredictorofdeathinheartfailure.In:“Thyroidand
heartfailure:frompathophysiologytoclinics”.G.Iervasi,A.PingitoreEds,Springer–VerlagItalia2009:pp.179-190.15.
PingitoreA. ,IervasiG.Thyroidhormone inheart failure:potential
therapeutic implications. In“Frontieres inCardiovascularDrug
Discovery”,A.Rahman,MIChoudharyEds,BenthamSciencePublishers2010,Vol1pp16.
Bottoni A., Lorenzoni G., Iervasi G. Tecniche diagnostiche per lo
studio della tiroide. In “Fondamenti di medicina nucleare”. D.
Volterrani,P.A.Erba,G.MarianiEds.Springer–VerlagItalia2010.pp617-650.TheundersignedauthorizestoprocessherpersonaldataforthepurposeshereininaccordancewiththetermsintheLegislativeDecreeNo196of30/06/2003
Pisa,30/11/2020
GiorgioIervasi
2020-12-10T14:15:43+0100Iervasi Giorgio